XinBei Uses, Dosage, Side Effects and more
XinBei has been used in trials studying the supportive care and prevention of Atrial Fibrillation.
| Attribute | Details |
|---|---|
| Trade Name | XinBei |
| Generic | Indobufen |
| Indobufen Other Names | Indobufen |
| Type | |
| Formula | C18H17NO3 |
| Weight | Average: 295.338 Monoisotopic: 295.120843411 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | China |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
XinBei is a reversible platelet aggregation inhibitor used to prevent coronary and peripheral artery occlusion.
XinBei is also used to associated treatment for these conditions: Platelet Aggregation
